MarketPulse

viral vectors

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Gene Therapy's Hidden Engine: AAV Vector Market Poised to Explode 22% Annually Through 2034

AAV vector manufacturing market to surge from $874M (2025) to $5.2B (2034) as gene therapy breakthroughs drive demand for specialized production infrastructure.
TMOCRLLZAGYgene therapybiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Oncolytic Virus Immunotherapy Market Poised to Reach $5B by 2031

Global oncolytic virus immunotherapy market projected to exceed $5 billion by 2031, driven by three approved therapies and 150+ clinical candidates advancing combination approaches.
BMYCELGrMRKRHHBYREPL+1clinical trialscancer treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Na

OXB Maps Investor Engagement Strategy With June Capital Markets Day and Conference Circuit

$OXB schedules June 2026 Capital Markets Day and four investor conferences, releasing FY2025 results March 26 to boost institutional engagement.
BMYCELGrinvestor conferencesFY 2025 results